Enzychem Lifesciences Corporation is a Manufacturer/Innovator, Biopharmaceutical company company operating in the pharmaceutical industry.
Enzychem Lifesciences Corporation is a Global New Drug Development Company that was founded on the most advanced life sciences and technologies of medicinal chemistry in July 1999. With its Global New Drug R&D center in Seoul and two GMP manufacturing plants in Korea, it has since been developing and producing APIs and functional health foods, and developing global new drugs. We produce an extensive array of curative products. Our flagship APIs include MRI Contrast Agent, D-Cycloserine, Terizidone, Erdosteine and other general APIs.
Company type
Manufacturer/Innovator, Biopharmaceutical company
Products and services
APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Enzychem Lifesciences Corporation, 59, Bio valley0ro, Jecheon-si,, Chungcheongbuk-do, Korea, Republic Of, Seoul
